B2C Wearables is Instructional Biology's consumer stream: wearable signal processing that turns the readings from a person's own wearable into a personal, informational report, with no recommendation to start, stop or change any medicine. This is the Instructional Twin, which informs a person's own choices and never administers anything. It is a separate system from the twin we are building for hospitals and prescribers in B2B Clinical.

B2C Wearables, revenue stream 09 of 10: on the seven-stage pipeline (Discovery, Development, Testing, Prototype, Ready for Demo, IND if required, Sales) it is at Development. Protected by: Digital Twin. Offered to: Consumers, as a personal, informational report from their own wearable. Markets its segments address: Digital twins in healthcare, USD 2.5 bn (2025), 30.0% CAGR.
B2C Wearables at a glance: its stage, the segments that protect it and the markets they address, as of October 29, 2026.

Where It Stands

B2C Wearables is at Development, the second of the seven stages on Our Pipeline: Discovery, Development, Testing, Prototype, Ready for Demo, IND (if required) and Sales.

Why Wearables

For most of medical history the body has been measured in snapshots: a blood pressure reading at an appointment, a fasting glucose test, a ten-second ECG strip. Continuous glucose monitors, smartwatches and patch sensors now record physiology every few minutes, for weeks, while people live their normal lives. The measurements that come out of them are called digital biomarkers. Wearable Health Monitoring and the Rise of Digital Biomarkers covers the landmark studies and their limits.

How the Twin Reads a Wearable

Our digital twin is designed to read wearable data in three steps: ingestion, calibration and estimation. The care is in the layers. A wrist sensor does not measure heart rhythm directly; it measures tiny changes in blood volume under the skin, and an algorithm turns that signal into a heart rate. The number on the screen is only as good as each layer beneath it, and we treat validation as a process, not a stamp.

The Segment That Protects It

B2C Wearables is protected by the Digital Twin segment of our IP portfolio. The patient digital twin is claimed in U.S. Patent Application No. 19/793,487 (claim 26). The claims are pending and have not been examined.

The Market Behind Its Segment

Each segment of our IP portfolio addresses a market that independent research firms already measure. The table gives that market's latest published size, its forecast and its compound annual growth rate (CAGR), from the same sources as Ten Revenue Streams.

Market and segmentSizeForecastCAGR
Digital twins in healthcare [1]
Digital Twin
USD 2.5 bn (2025)USD 33.4 bn by 203530.0%

These are estimates of whole markets, not Instructional Biology revenue or forecasts.

For partnership or licensing conversations about B2C Wearables, see Partnerships and Licensing.

Sources

  1. Roots Analysis, digital twins in healthcare market. giikorea.co.kr · rootsanalysis.com
This page describes a revenue stream and technology under development, in general terms, for a public and non-confidential audience. It is forward-looking, does not disclose proprietary process parameters, and is not a claim that any Instructional Biology product treats, cures or prevents any disease. Market figures are third-party estimates. Nothing on this page is medical advice. The report is informational and makes no recommendation to start, stop or change any medicine.
← Back to Ten Revenue Streams